Navigation Links
Oberthur Technologies XPon Offer
Date:4/23/2008

PARIS, April 23 /PRNewswire-FirstCall/ -- This press release is not and must not be, directly or indirectly, distributed or made public in Australia, Canada, Japan, South Africa or the United States of America. The Offer is not being made to persons in those jurisdictions or elsewhere where their participation requires further offer documents, filings or other measures in addition to those required by Swedish law. This is a translation of the original Swedish language press release. In the event of a dispute, the original Swedish language press release shall prevail.

98.7% of the Shares in XPonCard Group AB (publ) Tendered in the Offer or Acquired in the Market

On 19 February 2008, Oberthur Technologies S.A. ("Oberthur") announced a recommended cash offer (the "Offer") to acquire all shares in XPonCard Group AB (publ) ("XPonCard"). On 8 April 2008, Oberthur declared the Offer unconditional and extended the acceptance period until 18 April 2008.

A total of 38,239 shares, representing 0.9% of the shares and votes in XPonCard, have been tendered during the extension of the acceptance period. Consequently, a total of 3,889,604 shares in XPonCard, representing 86.7% of the shares and votes in XPonCard, have been tendered in the Offer. Up until and including 22 April 2008, Oberthur has also acquired in total 539,250 shares in the market, representing 12.0% of the shares and votes in XPonCard. Accordingly, following the expiration of the extended acceptance period and including the shares acquired in the market, Oberthur will own in aggregate 4,428,854 shares in XPonCard, representing 98.7% of the shares and votes in XPonCard.

Settlement in respect of shares tendered during the extension of the acceptance period is expected to commence on or about 30 April 2008. The Offer will not be extended further. However, Oberthur may acquire additional shares in XPonCard in the market.

As previously announced, Oberthur will initiate mandatory
'/>"/>

SOURCE Oberthur Technologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Beijing Genomics Institute adds AB SOLiD system to its next generation sequencing technologies
2. Europe develops new technologies to boost health of livestock
3. The bombardier beetle, power venom and spray technologies
4. Atmel and Phoenix Technologies Collaborate to Create Next-generation Security Solutions for PCs
5. Phoenix Technologies and Atmel Collaborate to Create Next-Generation Security Solutions for PCs
6. e-SMART Technologies Continues Delivery of Its New Super SMART Card in South Korea
7. e-Smart(R) Technologies Delivers Its New Super Smart Card(TM) in South Korea.
8. Material Technologies Holds First Electrochemical Fatigue Sensor Training for Private Inspection Firms
9. e-Smart(R) Technologies, Inc., Announces Next Generation Superthin Polyimide Flexible Circuit Biometric Super Smart Card(TM) card, the i am(TM) Card.
10. e-Smart Technologies, Inc. Responds to Information Subpoenas From Securities & Exchange Commission
11. e-Smart Technologies Responds to Press Release Issued By IDsmart LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...Dec. 3, 2009) Van Andel Research Institute (VAR...lant hormone abscisic acid (ABA) works at the mole...l stresses such as drought and cold. Their findin...engineer crops that thrive in harsh environments a... The findings could also have implications for str...
(Date:12/3/2009)...erly upset by a social snubbing? Your genetics, no...e long known that opium-like painkillers, called o...ome forms of emotional stress. Now, a new study re...ilig shows that small genetic differences in the g...nsity of people,s responses to social rejection. ...
(Date:12/3/2009)...have measured CO2 levels for the past three years ...ely inhabited rural area near Valladolid. The resu...ian Peninsula, show that the levels rose "signific..., physicists and meteorologists have been trying t...how these have evolved in the troposphere over var...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2Science Coalition commends Presidents strategy for innovation 10011 1Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding 57880 1Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding 57880 2Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding 57880 3VIDEO from Medialink and Siemens 3A Hi Tech Donation Benefits Childrens Health Fund 57878 1
...genome sequence was published. Now, nearly 200 bac...hits the scientific press most weeks. This burgeon...ing,?however. Having all these genome sequences ma...se human disease, how to control their spread, and...mparing genome sequences, scientists can learn muc...
...of a therapeutic cancer vaccine combining the synt... Coley Pharmaceutical), with a peptide antigen wer...igation. The paper shows that the CpG 7909 DNA seq...bility to recognize and destroy cancer cells. The ... of the Ludwig Institute for Cancer Research (LICR...
...ice in field trials in China report higher crop yi...lated health problems, according to a study by res...e University of California, Davis. , Results of t...journal Science. , "This paper studies two of the ...oduction trials, the last step before commercializ...
Other Biology News:Multiple Campylobacter Genomes Sequenced 2Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy 2Genetically modified rice in China benefits farmers' health, study finds 2Genetically modified rice in China benefits farmers' health, study finds 3Genetically modified rice in China benefits farmers' health, study finds 4
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...he Wisconsin Technology Council has teamed with Pr... to provide a searchable database of commercial re...sintechnologycouncil.com. The service can be acce...perty Search. , ,This new feature will allow techn...consin the ability to search a wide variety of spa...
...e of the IT industry news rags was making a big de...r players in radio frequency ID tag manufacture. A...ed that some customers were claiming failure rates... suggesting other factors like poor paper quality ...r was rolled up to tightly. , ,Whatever the cause...
...C. Johnson & Son Inc. made the No. 2 spot in the ...04. The top spot in this year,s list of technology...sconsin organzations, other than S.C. Johnson, mad... maintaining the annual list for the past seven ye...y agendas and usage, and examining their business ...
Other Biology Technology:The more things change ... 2The more things change ... 3S.C. Johnson lands in No. 2 spot in Information Week 500 list 2
IMAGEQUANT 400 WKSTN from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-Human IFN-Alpha / Beta R2 (IFNAR2) (CD118) Neutralizing Polyclonal Antibody, Unconjugated from PBL InterferonSource
Rabbit Anti-MYCOBACTERIUM TUBERCULOSIS Polyclonal Antibody, Unconjugated from AbD Serotec
ImageQuant 400 from GE Healthcare, formerly Amersham Biosciences
Biology Products: